692 related articles for article (PubMed ID: 24099276)
1. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review.
Wong TY; Ferreira A; Hughes R; Carter G; Mitchell P
Am J Ophthalmol; 2014 Jan; 157(1):9-25.e12. PubMed ID: 24099276
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and Diagnosis of Myopic Choroidal Neovascularization in Asia.
Chan NS; Teo K; Cheung CM
Eye Contact Lens; 2016 Jan; 42(1):48-55. PubMed ID: 26448447
[TBL] [Abstract][Full Text] [Related]
3. Myopic Choroidal Neovascularization: Review, Guidance, and Consensus Statement on Management.
Cheung CMG; Arnold JJ; Holz FG; Park KH; Lai TYY; Larsen M; Mitchell P; Ohno-Matsui K; Chen SJ; Wolf S; Wong TY
Ophthalmology; 2017 Nov; 124(11):1690-1711. PubMed ID: 28655539
[TBL] [Abstract][Full Text] [Related]
4. The role of anti-VEGF agents in myopic choroidal neovascularization: Current standards and future outlook.
Munk MR; Rückert R; Zinkernagel M; Ebneter A; Wolf S
Expert Opin Biol Ther; 2016; 16(4):477-87. PubMed ID: 26666589
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of periconus choroidal neovascularization in pathologic myopia.
Nagaoka N; Shimada N; Hayashi W; Hayashi K; Moriyama M; Yoshida T; Tokoro T; Ohno-Matsui K
Am J Ophthalmol; 2011 Sep; 152(3):420-427.e1. PubMed ID: 21696698
[TBL] [Abstract][Full Text] [Related]
6. Laser photocoagulation for choroidal neovascularisation in pathologic myopia.
Virgili G; Menchini F
Cochrane Database Syst Rev; 2005 Oct; (4):CD004765. PubMed ID: 16235380
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Myopic Macular Features in Dutch Individuals of European Ancestry With High Myopia.
Haarman AEG; Tedja MS; Brussee C; Enthoven CA; van Rijn GA; Vingerling JR; Keunen JEE; Boon CJF; Geerards AJM; Luyten GPM; Verhoeven VJM; Klaver CCW
JAMA Ophthalmol; 2022 Feb; 140(2):115-123. PubMed ID: 34913968
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of eyes with naïve subfoveal myopic choroidal neovascularization after intravitreal bevacizumab.
Yang HS; Kim JG; Kim JT; Joe SG
Am J Ophthalmol; 2013 Dec; 156(6):1201-1210.e2. PubMed ID: 24075429
[TBL] [Abstract][Full Text] [Related]
9. The Prevalence of Myopic Choroidal Neovascularization in the United States: Analysis of the IRIS(®) Data Registry and NHANES.
Willis JR; Vitale S; Morse L; Parke DW; Rich WL; Lum F; Cantrell RA
Ophthalmology; 2016 Aug; 123(8):1771-1782. PubMed ID: 27342789
[TBL] [Abstract][Full Text] [Related]
10. FACTORS INFLUENCING NEED FOR RETREATMENT AND LONG-TERM VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
Ng DS; Kwok AK; Tong JM; Chan CW; Li WW
Retina; 2015 Dec; 35(12):2457-68. PubMed ID: 26035400
[TBL] [Abstract][Full Text] [Related]
11. Myopic choroidal neovascularization: a 10-year follow-up.
Yoshida T; Ohno-Matsui K; Yasuzumi K; Kojima A; Shimada N; Futagami S; Tokoro T; Mochizuki M
Ophthalmology; 2003 Jul; 110(7):1297-305. PubMed ID: 12867382
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor inhibitor use and treatment approach for choroidal neovascularization secondary to pathologic myopia.
Pakzad-Vaezi K; Mehta H; Mammo Z; Tufail A
Expert Opin Biol Ther; 2016 Jul; 16(7):873-81. PubMed ID: 26985834
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, treatment pattern and health care utilization of myopic choroidal neovascularization: a population based study.
Yang MC; Chen YP; Tan EC; Leteneux C; Chang E; Chu CH; Lai CC
Jpn J Ophthalmol; 2017 Mar; 61(2):159-168. PubMed ID: 28062929
[TBL] [Abstract][Full Text] [Related]
14. Choroidal neovascularization in pathological myopia.
Neelam K; Cheung CM; Ohno-Matsui K; Lai TY; Wong TY
Prog Retin Eye Res; 2012 Sep; 31(5):495-525. PubMed ID: 22569156
[TBL] [Abstract][Full Text] [Related]
15. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of patients with a favorable natural course of myopic choroidal neovascularization.
Hayashi K; Ohno-Matsui K; Yoshida T; Kobayashi K; Kojima A; Shimada N; Yasuzumi K; Futagami S; Tokoro T; Mochizuki M
Graefes Arch Clin Exp Ophthalmol; 2005 Jan; 243(1):13-9. PubMed ID: 15290153
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and Treatment of Myopic Maculopathy.
Yokoi T; Ohno-Matsui K
Asia Pac J Ophthalmol (Phila); 2018; 7(6):415-421. PubMed ID: 30255668
[TBL] [Abstract][Full Text] [Related]
18. Long-term variable outcome of myopic choroidal neovascularization treated with ranibizumab.
Cohen SY; Nghiem-Buffet S; Grenet T; Dubois L; Ayrault S; Fajnkuchen F; Delahaye-Mazza C; Quentel G; Tadayoni R
Jpn J Ophthalmol; 2015 Jan; 59(1):36-42. PubMed ID: 25416566
[TBL] [Abstract][Full Text] [Related]
19. Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study.
Xu L; Wang Y; Li Y; Wang Y; Cui T; Li J; Jonas JB
Ophthalmology; 2006 Jul; 113(7):1134.e1-11. PubMed ID: 16647133
[TBL] [Abstract][Full Text] [Related]
20. Continued Increase of Axial Length and Its Risk Factors in Adults With High Myopia.
Du R; Xie S; Igarashi-Yokoi T; Watanabe T; Uramoto K; Takahashi H; Nakao N; Yoshida T; Fang Y; Ohno-Matsui K
JAMA Ophthalmol; 2021 Oct; 139(10):1096-1103. PubMed ID: 34436537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
